Telix (TLX) to Buy Germany's ITM for up to $2.35 Billion to Lock in its Cancer Isotope Supply
Telix Pharmaceuticals Limited (NASDAQ:TLX) agreed on September 21 to acquire ITM Isotope Technologies Munich SE. The deal is worth up to $2.35 billion.
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| Officer | $9.66 | 2,071 | $19,997.58 | 13,992 | 2026-09-07 | Filing |
| Officer, Director | $14.87 | 33,435 | $497,178.45 | 20,742,935 | 2026-04-29 | Filing |
| Officer, Director | $14.48 | 34,500 | $499,560.00 | 20,709,500 | 2026-04-28 | Filing |
September 22nd, 2026 - Hedge Funds News
June 16th, 2026 - Hedge Funds News
April 27th, 2026 - News
April 18th, 2026 - Hedge Funds News
February 27th, 2026 - News
February 26th, 2026 - Hedge Funds News
February 20th, 2026 - News Transcripts
January 8th, 2026 - Hedge Funds News
December 18th, 2025 - News
December 17th, 2025 - Hedge Funds News
Returns since its inception in May 2014 (through June 2, 2026)
Subscribe Now30 day money back guarantee. Cancel anytime.
Past performance does not guarantee future returns. Click to see how the portfolio is constructed.